The Board of Directors of Revance Therapeutics (the "Company") sets high standards for the Company's employees, officers and directors. Implicit in this philosophy is the importance of sound corporate governance. It is the duty of the Board of Directors to serve as a prudent fiduciary for shareholders and to oversee the management of the Company's business. To fulfill its responsibilities and to discharge its duty, the Board of Directors follows the procedures and standards that are set forth in these guidelines. These guidelines are subject to modification from time to time as the Board of Directors deems appropriate in the best interests of the Company or as required by applicable laws and regulations.

Audit Committee Charter

Brand Strategy Committee Charter

Compensation Committee Charter

Nominating and Corporate Governance Committee

Code of Conduct & Ethics

On September 21, 2023, the Board of Directors of Revance Therapeutics, Inc. amended and restated the Code of Business Conduct and Ethics (the "Code") that applies to all of Revance Therapeutics, Inc. employees, officers and directors. The Code was amended to revise the hotline information for the anonymous reporting of complaints. The revisions to the Code did not relate to or result in any waiver, explicit or implicit, of any provision of the Code in effect prior to its amendment and restatement.

Corporate Governance Guidelines

Insider Trading Policy

Whistleblower Policy

2022 ESG Report